About the Campaign
The Campaign for Patient Access was launched by the American College of Cardiology in December 2009 as a national effort to reverse Medicare physician fee schedule cuts that threatened cardiovascular care. The site provided background on the issue, the ACC's legislative and legal response, resources for patients and practices, a newsroom tracking coverage across the country, and ways for supporters to share their stories and support the campaign.
From the Newsroom
Medicare Meltdown: Access to Health Care in "Critical Condition"
A press release warning that cardiology access was in critical condition due to Medicare payment cuts.
Read more
Cardiology Takes Legal Action Against Medicare
The ACC filed suit against HHS Secretary Kathleen Sebelius over the 2010 Physician Fee Schedule.
Read more
ACC Statement on Health Care Reform
The ACC used the State of the Union address to highlight the need to reverse the Medicare cuts.
Read more
Medicare Patients and Physicians Join Petition Drive
Patients and physicians in Washington, DC joined a petition drive calling on Congress for Medicare reform.
Read moreHow Payment Cuts Can Limit Access to TAVR
Transcatheter aortic valve replacement has transformed care for people with severe aortic stenosis. Instead of requiring open-heart surgery, TAVR can replace a diseased aortic valve through a catheter, often allowing patients to recover sooner and avoid some of the risks associated with surgical valve replacement. For older adults and people with multiple health conditions, that less invasive approach may be the most suitable treatment option.
Access to TAVR depends on more than clinical innovation. Patients need timely referrals, advanced imaging, a specialized heart team, an equipped hospital, trained personnel, and follow-up care. Each part of that system requires stable funding. When Medicare physician fee schedule reductions lower payment for the work involved in evaluating and treating cardiovascular disease, the impact can reach far beyond a practice’s balance sheet.
The effect of cuts on access to TAVR may appear gradually. A cardiology practice may postpone a new imaging investment, a hospital may limit procedural capacity, or a rural referral network may become harder to maintain. These decisions can lengthen the path from symptoms to diagnosis and from diagnosis to valve replacement.
Why TAVR Depends on a Stable Care System
TAVR is a coordinated service rather than a single procedure. A patient may first see a primary care clinician, then a general cardiologist, followed by imaging specialists, interventional cardiologists, cardiac surgeons, anesthesiology staff, nurses, and rehabilitation professionals. The heart team reviews symptoms, valve severity, anatomy, frailty, kidney function, surgical risk, and the patient’s goals before recommending treatment.
Physician payment supports the evaluation surrounding the procedure. Specialists must interpret echocardiograms and CT scans, discuss treatment choices, obtain informed consent, coordinate medication management, and monitor recovery. Those activities require time and expertise even when they do not appear as a separate intervention.
The patient access campaign has highlighted how Medicare payment policy can affect the availability of cardiovascular services. A reduction in professional reimbursement can be especially consequential when practices are already facing higher staffing, technology, malpractice, and administrative costs.
Where Financial Pressure Reaches Patients
Cuts can affect TAVR access through several connected channels. A cardiology group that receives less payment for complex visits may have fewer resources to hire advanced practice clinicians, expand scheduling, or maintain dedicated valve clinic staff. Patients may then wait longer for consultation or travel farther for an appointment.
Hospitals also evaluate the financial sustainability of structural heart programs. TAVR requires specialized catheterization or hybrid operating rooms, imaging equipment, sterile supplies, intensive care capabilities, and staff who perform these procedures frequently enough to maintain expertise. If reimbursement does not keep pace with operating costs, a hospital may reduce available procedure days or decide against expanding its program.
The effect is often sharper in rural and underserved communities. Smaller hospitals may lack a full heart team and depend on partnerships with larger medical centers. If transportation, referral coordination, or specialist coverage becomes less reliable, patients can face additional delays. Those delays may burden people who have limited mobility, modest incomes, or no nearby family support.
How Delays Change the Clinical Path
Severe aortic stenosis can progress while a patient waits for evaluation. Symptoms may begin with exertional shortness of breath or reduced stamina and later include chest pain, dizziness, fainting, or heart failure. A delayed referral can mean that a person reaches valve specialists with greater weakness, fluid retention, or reduced ability to tolerate treatment.
Early assessment gives clinicians time to confirm the diagnosis and consider the full range of options. Echocardiography measures valve narrowing and heart function, while CT imaging helps determine whether a transcatheter valve can be safely delivered and which device size is appropriate. When access to these services is constrained, the diagnostic process may become fragmented.
Delays can also affect caregiver planning and shared decision-making. Families may need time to understand TAVR, surgical replacement, medical therapy, and palliative approaches. A rushed decision made after repeated emergency visits is different from a planned treatment discussion held when the patient is stable.
The consequences are not uniform. Older adults with several chronic illnesses may be more vulnerable to hospitalization while waiting. Patients from communities with fewer cardiology services may have less opportunity to receive a second opinion or participate in a formal multidisciplinary valve evaluation.
Comparing the Main Access Pressures
The relationship between reimbursement and access is not automatic, and payment changes do not affect every program equally. Large academic centers may have reserves or multiple service lines that help absorb reductions. Smaller practices and community hospitals may have less flexibility, especially when fixed costs are high and patient volume is limited.
| Access pressure | How cuts can contribute | Possible patient effect |
|---|---|---|
| Specialist evaluation | Less support for complex consultations and care coordination | Longer waits for valve clinic appointments |
| Diagnostic imaging | Reduced capacity to staff or schedule echocardiography and CT services | Slower confirmation of disease severity and anatomy |
| Heart-team staffing | Difficulty sustaining interventional, surgical, nursing, and administrative roles | Fewer coordinated treatment discussions |
| Hospital procedure capacity | Pressure to limit TAVR days or defer equipment upgrades | Longer scheduling delays or travel to another center |
| Rural referrals | Weaker financial support for outreach and shared-care networks | Greater distance and more missed care opportunities |
| Follow-up management | Less time for post-procedure monitoring and medication review | Gaps in recovery support and complication detection |
These pressures can reinforce one another. A patient who cannot obtain timely imaging may not reach the valve team promptly. A program with limited procedure capacity may prioritize the most urgent cases, leaving others in an extended monitoring period. A patient who must travel several hours may postpone appointments, especially when symptoms fluctuate.
Protecting Timely Valve Care
Policymakers should examine the complete episode of TAVR care rather than focusing only on the procedure itself. Payment policy needs to recognize evaluation, imaging interpretation, care coordination, informed consent, post-procedure management, and the clinical judgment required to select appropriate candidates. Value-based models can support quality, but they should not unintentionally penalize programs serving medically complex or geographically isolated patients.
Monitoring access measures can make hidden effects more visible. Useful indicators include the time from referral to echocardiography, from confirmed severe stenosis to heart-team review, and from treatment recommendation to TAVR. Programs should also track cancellations, emergency admissions while patients are waiting, travel distance, insurance-related delays, and differences in access by race, income, age, and geography.
Stable staffing is equally important. Nurse coordinators, imaging specialists, physician assistants, and referral navigators often keep a valve program functioning smoothly. When payment reductions force practices to eliminate these roles, physicians may spend more time on administrative work and less time seeing patients. Supporting the full care team can improve both efficiency and patient experience.
Hospitals and physician groups can also strengthen regional partnerships. Shared protocols, telehealth consultations, mobile imaging arrangements, and formal referral agreements may help smaller communities connect patients to high-volume TAVR centers. These approaches cannot replace local investment, but they can reduce unnecessary duplication and make specialist advice available earlier.
Practical Steps For Preserving Access
Patients, clinicians, health systems, and policymakers each have a role in identifying access problems before they become permanent. The following actions can help maintain a reliable pathway to structural heart care:
- Track referral-to-treatment time and review delays by location, insurance status, and patient demographics.
- Protect dedicated valve-clinic coordinators who organize imaging, consultations, education, and follow-up.
- Build formal partnerships between rural hospitals, community cardiologists, and experienced TAVR centers.
- Include post-procedure monitoring, rehabilitation, medication management, and transportation needs in access planning.
- Share patient and clinician experiences with policymakers when payment changes threaten local cardiovascular services.
Patients can also help by reporting worsening breathlessness, fainting, chest discomfort, swelling, or a sudden decline in activity to a healthcare professional. Symptoms should not be dismissed as normal aging. A prompt evaluation may clarify whether aortic stenosis is present and whether referral to a valve specialist is appropriate.
Clinicians can document the operational effects of reimbursement changes, including reduced appointment availability, delayed imaging, staffing losses, and patients traveling long distances for care. Clear evidence helps distinguish temporary scheduling problems from broader erosion of cardiovascular capacity.
Keep A Reliable Route To Valve Treatment
TAVR can be life-changing for appropriately selected patients, but its benefits depend on access to the entire care pathway. Medicare payment reductions that weaken specialist practices, imaging services, heart teams, or referral networks can make treatment less timely and less equitable, even when the procedure itself remains available.
Protecting access requires attention to the practical realities of cardiovascular care. Patients and families can learn the warning signs of aortic stenosis, ask how referrals are handled, and seek timely evaluation when symptoms change. Physicians, hospitals, and advocates can document barriers and support payment policies that sustain high-quality valve programs.
Sharing real experiences with policymakers and participating in organized efforts to preserve cardiovascular services can help keep TAVR within reach for patients who need it. A strong access system gives every eligible patient a fair opportunity to receive an accurate diagnosis, a careful heart-team assessment, and treatment at the right time.
Campaign for Patient Access